The Cell and Molecular Biology Core provides essential services for the proposed Program Project. The capabilities of cellular and molecular biology have only recently been harnessed in our studies which focus on pathophysiological characteristics of solid tumors. We have thus assembled as part of our program, a team of cellular and molecular biologists to assist in the investigation of the relationships between tumor physiology and the expression of molecular determinants to assist in the investigation of the relationships between tumor physiology and the expression of molecular determinants. The facilities and services of this important Core will provide on-site expertise, equipment, and assay protocols to our Project Leaders who are primarily biomedical engineers with relatively limited experience in molecular, cellular and morphological techniques. The molecular biology component of the Core will provide the expertise, equipment, assay protocols, and essential reagents for the characterization of gene expression and protein distribution. These routine services will include the isolation and purification of DNA, RNA and proteins, in situ hybridization, Southern, Northern and Western assays, generation of DNA constructs, and modification of tumor cell lines by transfection and genotyping characterization. The cellular biology component will provide the expertise and services for cell culture (maintenance of tumor cell lines and genetically transfected cell lines, quality control, and maintenance of supplies). The morphology component will provide the expertise and routine services for histology and immunolabeling (providing equipment, supplies and protocols, fixation, embedding and sectioning of tissues, and staining using established immunohistochemical and immunocytochemical procedures). In addition to provide strategic consultation in the design of experimental procedures, to introduce state- of-the-art techniques, and assist in the completion of experiments and interpretation of data for molecular, cellular and morphology studies. Finally, the Core personnel will assure reagent and antibody quality, manage biological information (e.g DNA, protein sequences from Genbank), acquire and store research materials, and maintain essential logs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA080124-01A1
Application #
6402415
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2000-08-11
Project End
2005-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Carr, Jessica A; Franke, Daniel; Caram, Justin R et al. (2018) Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green. Proc Natl Acad Sci U S A 115:4465-4470
Fukumura, Dai; Kloepper, Jonas; Amoozgar, Zohreh et al. (2018) Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol 15:325-340
Pereira, Ethel R; Kedrin, Dmitriy; Seano, Giorgio et al. (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403-1407
Dixon, Karen O; Schorer, Michelle; Nevin, James et al. (2018) Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity. J Immunol 200:3000-3007
Samaha, Heba; Pignata, Antonella; Fousek, Kristen et al. (2018) A homing system targets therapeutic T cells to brain cancer. Nature 561:331-337
Binnewies, Mikhail; Roberts, Edward W; Kersten, Kelly et al. (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541-550
Nia, Hadi T; Datta, Meenal; Seano, Giorgio et al. (2018) Quantifying solid stress and elastic energy from excised or in situ tumors. Nat Protoc 13:1091-1105
Ina Ly, K; Vakulenko-Lagun, Bella; Emblem, Kyrre E et al. (2018) Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep 8:17062
Nowak-Sliwinska, Patrycja; Alitalo, Kari; Allen, Elizabeth et al. (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21:425-532
Zhao, Yingchao; Liu, Pinan; Zhang, Na et al. (2018) Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models. Proc Natl Acad Sci U S A 115:E2077-E2084

Showing the most recent 10 out of 320 publications